MAP1LC3B and ovarian cancer: By knocking down LC3B (LC3B−) in ovarian cancer cell lines, western blot showed that compared with the control group, the expression of LC3B, Atg7 and MDR1 was decreased in the LC3B− group (Fig. 2a–c).